Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRK6 | P43250 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.34 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | ERN1 | O75460 | 1/20 | 0.34 |
| ▸ | MC4R | P32245 | 3/20 | 0.34 |
| ▸ | MC5R | P33032 | 3/20 | 0.34 |
| ▸ | MC3R | P41968 | 3/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14350965 | 0.92 | PPARA (0.35) | GRK6ALDH1A1MEN1KMT2ASLC6A9 | |
| SCHEMBL3646605 | 0.87 | PTPN1 (0.44) | GRK6ALDH1A1PTPN1MEN1KMT2A | |
| SCHEMBL14338910 | 0.81 | MAPT (0.38) | GRK6ALDH1A1KMT2ASLC6A9HDAC1 | |
| SCHEMBL862339 | 0.78 | CXCR4 (0.35) | ALDH1A1MEN1KMT2APPARGMC4R | |
| SCHEMBL13601031 | 0.75 | CXCR4 (0.34) | PPARGMC4RMC5RMC3R | |
| SCHEMBL13214435 | 0.71 | PPARG (0.34) | PPARG | |
| SCHEMBL2474794 | 0.69 | CXCR4 (0.50) | KMT2AHDAC1PPARGHDAC3HDAC2 | |
| SCHEMBL4094117 | 0.69 | CXCR4 (0.50) | KMT2AHDAC1PPARGHDAC3HDAC2 | |
| SCHEMBL14721381 | 0.67 | MCL1 (0.48) | GRK6ALDH1A1PTPN1MEN1KMT2A | |
| SCHEMBL28810821 | 0.67 | MCL1 (0.48) | GRK6ALDH1A1PTPN1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070286810-A1 | Nanoparticles comprising lanthanide chelates | WALLAC OY (FI) | 2007-12-13 | — | — | US | disclosed |
| US-20070286810-A1 | Nanoparticles comprising lanthanide chelates | WALLAC OY (FI) | 2007-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070286810-A1 | Nanoparticles comprising lanthanide chelates | CLTA, LASP1, L3MBTL3 | GRK6 4647/4885ALDH1A1 4106/4885PTPN1 1459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.